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Introduction
The DNA damage response consists of a complex protein net-
work that mediates the detection of damaged DNA and regu-
lates multiple cellular processes (Zhou and Elledge, 2000; 
Kolodner et al., 2002; Nyberg et al., 2002; Rouse and Jackson, 
2002; McGowan and Russell, 2004). In Saccharomyces cerevi-
siae, an evolutionarily conserved kinase cascade consisting of 
Mec1, Tel1, Rad53, and Dun1 is responsible for amplifying the 
DNA damage signal from DNA damage recognition enzymes 
and transducing such signal to downstream targets in the form 
of protein phosphorylation (Longhese et al., 1998; Foiani et al., 
2000). Although Mec1 and Tel1 are involved in sensing DNA 
damage (Jackson, 1996), Rad53 and Dun1 appear to function as 
effector kinases to regulate multiple cellular processes, such as 
the cell cycle, DNA replication, chromosome segregation, his-
tone turnover, gene transcription, and possibly DNA repair 
(Allen et al., 1994; de la Torre Ruiz and Lowndes, 2000; Zhao 
and Rothstein, 2002; Gunjan and Verreault, 2003; Tercero et al., 
2003; Krishnan et al., 2004). Rad53 is critical for cells to cope 
with various DNA damage stresses, as cells with Rad53 dele-
tion or kinase-dead mutations are hypersensitive to genotoxic 
stresses (Allen et al., 1994; Sun et al., 1996; Pellicioli et al., 
1999). In response to DNA damage or stalled replication forks, 
Rad53 is hyperphosphorylated and activated in a Mec1-dependent 
manner (Sun et al., 1996; Emili, 1998; Vialard et al., 1998). The 
activation of Rad53 is accompanied by its autophosphorylation, 
induced by its association with the hyperphosphorylated forms 
of the adaptor proteins Rad9 or Mrc1 (Alcasabas et al., 2001; 
Gilbert et al., 2001; Schwartz et al., 2002). Rad53 appears to be 
directly involved in the regulation of cell cycle, as its overex-
pression leads to cell cycle arrest even in the absence of exoge-
nous DNA damage stresses (Sun et al., 1996). Despite its 
importance, the targets of Rad53 in the DNA damage response 
are poorly known.
Rad53 consists of a central serine/threonine kinase do-
main, fl  anked by an N-terminal Forkhead associated 1 (FHA1) 
domain and a C-terminal FHA2 domain (Durocher et al., 1999). 
The FHA domain is found in a wide range of signaling proteins, 
with known roles in mediating protein–protein interactions 
through the binding of phosphorylated substrates (Hofmann 
and Bucher, 1995; Durocher and Jackson, 2002). DNA damage–
induced interaction between Rad53 and hyperphosphorylated 
Rad9 is mediated by both the FHA1 and -2 domains of Rad53. 
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Although differences in the binding specifi  city of both domains 
were found using an oriented phosphopeptide library approach 
(Durocher et al., 2000), the presence of either domain alone is 
suffi   cient for Rad53 activation (Schwartz et al., 2002; Pike 
et al., 2003). Additionally, the FHA domains likely mediate the 
targeting of Rad53 to other proteins for their regulation by 
Rad53. For example, chromatin assembly protein Asf1 and 
phosphatase Ptc2 were shown to bind to the FHA1 domain of 
Rad53 in a phosphorylation-dependent manner (Emili et al., 
2001; Hu et al., 2001; Leroy et al., 2003; Schwartz et al., 2003). 
Several other proteins have been shown to be regulated in a 
Rad53-dependent manner. Swi6 is an essential regulatory sub-
unit of two different START-dependent transcription factors, 
Swi4 and Mbp1, which regulate the transcription of many genes 
involved in DNA replication (Koch and Nasmyth, 1994). Swi6 
appears to undergo Rad53-dependent phosphorylation in re-
sponse to DNA damage stresses and was suggested to be a sub-
strate of Rad53 (Sidorova and Breeden, 2003). Dun1 was also 
shown to be phosphorylated and activated by Rad53 (Bashkirov 
et al., 2003). Furthermore, several other proteins were found to 
interact with Rad53, including Cdc7/Dbf4 (Duncker and Brown, 
2003), Kap95 (Smolka et al., 2005), Yta7 (Smolka et al., 2005), 
Mdt1 (Pike et al., 2004), and others (Ho et al., 2002). Despite 
these studies, the mechanism by which Rad53 regulates cell 
growth in response to DNA damage and replication stress re-
mains poorly understood.
The cell cycle of the budding yeast consists of highly 
coordinated events, including bud emergence, polarized cell 
growth, and protein traffi  cking, which are synchronized with 
the initiation and progression of DNA replication. After suc-
cessful completion of DNA replication, mitosis and cytokinesis 
occur, and a new round of cell cycle begins (Lew et al., 1997). 
At the initiation of S-phase, bud emergence is accompanied by 
the localization of bud site selection proteins and septins 
(Gladfelter et al., 2001; Longtine and Bi, 2003). Septins are a 
family of conserved proteins that form fi  laments at the cortex of 
the mother-bud neck (Versele and Thorner, 2005). Localization of 
septins to the bud neck persists throughout the cell cycle except 
for disassembly and reassembly during G1 phase (Gladfelter 
et al., 2005). In budding yeast, genes encoding septins, i.e., Cdc3, 
Cdc10, Cdc11, and Cdc12, were identifi  ed through the isolation 
of temperature-sensitive mutations that prevented cytokinesis at 
restrictive temperature, resulting in the formation of chains of 
multinucleated and multibudded cells (Hartwell, 1971). More 
recently, a fi  fth member of the septin family was identifi  ed, 
namely, Shs1 (seventh homologue of septin) (Mino et al., 1998). 
Septins are known to perform important functions in spindle 
orientation, bud-site selection, the establishment and mainte-
nance of polarized bud growth, the switch from polarized to 
isotropic bud growth, cell cycle, and morphogenesis check-
points (Barral et al., 1999; Longtine et al., 2000; Segal and 
Bloom, 2001; Kusch et al., 2002; Gladfelter et al., 2005). 
Increasingly, the regulatory role of septins in coordinating mul-
tiple steps in cell cycle progression is being revealed (Field and 
Kellogg, 1999; Longtine and Bi, 2003; Gladfelter et al., 2005).
In this study, we performed a proteomic screen to identify 
proteins that bind to the FHA domains of Rad53. This led to the 
fi  nding that the FHA1 domain of Rad53 coordinates the interac-
tion between Rad53 and a wide variety of proteins. In contrast, 
the FHA2 domain appears to have a rather specialized role in 
binding to Rad9 after DNA damage treatment. Among the 
FHA1 binding proteins, septins and their associated proteins 
represent a major functional group. We present evidence that 
Rad53 may play a role in the regulation of polarized cell growth 
in response to DNA replication stress.
Results
Proteomic screening of Rad53 FHA binding 
proteins using a PATH approach
A proteomic approach was developed to identify Rad53 FHA 
binding proteins present in yeast cell extracts. Various N-terminal 
PATH (protein A–Tev–His; Fig. 1 A) fusion FHA domains bound 
to the IgG resin were used in the affi  nity purifi  cation. As shown 
in Fig. 1 B, the FHA binding proteins were purifi  ed using a 
 tandem  affi  nity purifi  cation (TAP) method (see Materials and 
methods). As a control, the same purifi  cation was performed 
using a mutant FHA protein carrying a point mutation previ-
ously shown to reduce its binding to phosphorylated sub-
strates (R70A for FHA1 and R605A for FHA2; Durocher et al., 
1999). Fig. 1 C shows the purifi  ed FHA binding proteins. 
Figure 1.  PATH puriﬁ  cation of the Rad53 FHA1 and -2 domain binding 
proteins. (A) Schematics of the PATH tag, consisting of protein A, TEV site, 
and 6xHis tag. The PATH tag is fused to the N terminus of various FHA do-
mains, which are expressed in bacteria. IgG-Sepharose resin is used for 
their puriﬁ  cation. (B) WT and mutant PATH-FHA resins are used for a paral-
lel puriﬁ  cation of FHA binding proteins in an equal amount of yeast cell ex-
tract. After puriﬁ  cation, the d0-leucine containing light N-isotag is used to 
label the WT FHA binding proteins, and the d10-leucine containing heavy 
N-isotag is used to label proteins from the mutant FHA puriﬁ  cation. The la-
beled samples are combined and analyzed by mass spectrometry (Smolka 
et al., 2005). Contaminant proteins are expected to be common to both 
WT and mutant FHA puriﬁ  cations, thus showing similar abundance as de-
tected by mass spectrometry. In contrast, the speciﬁ  c binding proteins of 
WT FHA domain are expected to be detected as a single peak containing 
only the light N-isotag. In this way, the speciﬁ  c FHA binding proteins will 
be determined. (C) Silver staining of 0.5% of the puriﬁ  ed proteins of the 
FHA1 and -2 domains of Rad53 from untreated cells. Asterisks indicate the 
speciﬁ  c bands present in the sample of proteins puriﬁ  ed with WT FHA1.FHA DOMAIN–MEDIATED PROTEIN INTERACTION NETWORK OF RAD53 • SMOLKA ET AL. 745
Although contaminant proteins, i.e., bands common in both 
wild type (WT) and mutant FHA purifi  cation, are still present, 
bands specifi  c to the WT FHA1 can be seen. To identify the 
specifi  c binding proteins of WT FHA domain, we used stable 
isotope labeling–based quantitative mass spectrometry, as illus-
trated in Fig. 1 B. Each purifi  ed sample was independently di-
gested with trypsin and then labeled with a stable isotope 
containing N-isotag reagent (light N-isotag for WT sample and 
heavy N-isotag for mutant sample; see Materials and methods; 
Smolka et al., 2005). The labeled samples were combined and 
analyzed by mass spectrometry for identifi  cation and quantifi  -
cation of proteins (Fig. 1 B). Proteins identifi  ed in the WT FHA 
purifi  cation, but not the mutant FHA purifi  cation, as determined 
by their isotope labeling, were then considered specifi  c FHA 
binding proteins for further validation studies.
In a separate experiment, to identify DNA damage–
  induced changes in the FHA binding proteins, WT PATH-FHA1 
(or PATH-FHA2) resin was used to purify proteins from un-
treated cells and methyl methanesulfonate (MMS)–treated cells 
(the eluted proteins had similar patterns like Fig. 1 C and are not 
depicted). The purifi  ed proteins from untreated cells were di-
gested by trypsin and labeled with the light N-isotag, and those 
from MMS-treated cells were labeled with the heavy N-isotag. 
Quantitative mass spectrometry was again used to identify any 
MMS-induced changes in the specifi  c binding proteins of the 
FHA domains.
The Rad53 FHA1 domain mediates 
a complex protein interaction network 
that includes the ﬁ  ve related septins
The specifi  c binding proteins of FHA domains of Rad53 are 
summarized in Table I. Although most of them interact with the 
FHA1 domain of Rad53 independent of DNA damage, Rad9 
and Mrc1 interact with the FHA1 domain only after MMS 
treatment. Rad9 was also found to bind to the FHA2 domain of 
Rad53 after MMS treatment, consistent with previous fi  ndings 
(Sun et al., 1998; Vialard et al., 1998). Additionally, Asf1 and 
Ptc2, both known FHA1 binding proteins (Emili et al., 2001; 
Hu et al., 2001; Leroy et al., 2003), were identifi  ed. The identi-
fi  cation of these known FHA binding proteins validates the 
PATH approach. Interestingly, Swi6 and its associated proteins, 
Swi4, Mbp1, and Whi5, were found to bind to the FHA1 do-
main of Rad53, further supporting a previously identifi  ed link 
between Rad53 and Swi6 (Sidorova and Breeden, 2003). 
Because the purifi  cation was performed under nondenaturing 
conditions, it is not surprising that protein complexes were puri-
fi  ed and identifi  ed.
Although the FHA2 domain was found to bind only Rad9, 
the FHA1 domain of Rad53 binds to a wide variety of proteins, 
most of which are novel (Table I). Interestingly, several cyto-
solic proteins were found, including the septins (Cdc10, Cdc11, 
Cdc12, Cdc3, and Shs1) and proteins involved in bud site selec-
tion (Bud3, Bud4, and Bud14), all of which localize to the bud 
neck. Based on the number of identifi  ed peptides for each pro-
tein identifi  ed (Table I), a crude indicator of protein abundance, 
we deduce that the septins are among the more abundant FHA1 
binding proteins. To confi  rm the specifi  city of FHA1 binding, 
protein extracts of strains containing TAP- or HA-tagged genes 
of interest were analyzed by affi  nity purifi  cation with either WT 
or mutant GST-FHA proteins immobilized on glutathione res-
ins, and the bound protein was analyzed by Western blotting. 
Fig. 2 A confi  rms that in MMS-treated cells, Rad9 binds to both 
the FHA1 and -2 domains, whereas Mrc1 binds to only the 
FHA1 domain. The specifi  city of binding between septins and 
the FHA1 domain was similarly confi  rmed by Western blot 
analysis (Fig. 2 B). Furthermore, as shown in Fig. 2 B, deletion 
of genes encoding any of the septin-associated proteins Bud3, 
Bud4, or Bud14, as well as deletion of SHS1, did not affect the 
binding of the FHA1 domain to Cdc11. Deletion of CDC10, 
which results in cells with abnormal cell morphology (not de-
picted), was found to impair the ability of FHA1 domain to 
bind Cdc11 (Fig. 2 B). Collectively, the results show that the 
FHA1 domain most likely binds to septins directly in a Cdc10-
dependent manner.
Binding specifi  cities of most other FHA1 binding proteins 
have also been confi  rmed using the same approach, and the re-
sults are shown in Fig. S1 (available at http://www.jcb.org/cgi/
content/full/jcb.200605081/DC1). In all cases, the R70A muta-
tion, which is known to diminish the binding of the FHA1 
domain to phosphopeptides (Durocher et al., 1999), greatly 
  reduces the binding of the identifi  ed FHA1 binding proteins.
Rad53 can transiently localize to the bud 
neck in an FHA1-dependent manner
The fi  nding that the septin complex binds to the FHA1 domain 
was unexpected because Rad53 is a known nuclear protein and 
septins are known to localize at the bud neck. We next asked 
whether a localization of Rad53 at the bud neck could be 
  detected. As shown in Fig. 3 A, the majority of GFP-tagged WT 
Rad53 is nuclear, although some heterogeneous GFP signal was 
detected in the cytoplasm upon close inspection. It is diffi  cult to 
observe the localization of WT Rad53 at the bud neck, espe-
cially in late S-phase, when the GFP signal from nuclear Rad53 
is within close proximity to the bud neck and overwhelms any 
possible signal from the bud neck. To better visualize the local-
ization of Rad53 outside of the nucleus, we generated a Rad53 
mutant in which a putative nuclear localization signal (NLS) in 
the C-terminal region of Rad53 was removed (Smolka et al., 
2005; see Materials and methods). Results in Fig. 3 A confi  rm 
the loss of predominant nuclear localization of the Rad53 NLS 
truncation mutant. In unsynchronized cells, the Rad53 NLS 
mutant was detected in the bud neck of a small percentage of the 
cells ( 8%; Fig. 3 B). Interestingly, all of the cells showing 
positive Rad53 localization to the bud neck had large buds and 
a still undivided nucleus. We then examined the effect of DNA 
damage on the localization of the Rad53 NLS mutant. Exposure 
to MMS or hydroxyurea (HU) drastically increases the percent-
age of cells showing the localization of Rad53 to the bud neck, 
again in cells with large buds (Fig. 3 A). Closer inspection 
shows that the GFP signal of the Rad53 NLS mutant appears as 
a double ring–like pattern (Fig. 3 A, enlarged panel). Importantly, 
a Rad53 NLS mutant containing an additional FHA1 domain 
R70A mutation fails to localize to the septins, further indicat-
ing that the localization of Rad53 to bud neck is mediated JCB • VOLUME 175 • NUMBER 5 • 2006  746
through its FHA1 domain. We also analyzed cells at different 
times after the release from α-factor arrest and did not observe 
the same striking GFP signal at the septin ring as observed 
after HU or MMS treatment (unpublished data). Importantly, 
Rad53-GFP cells exhibited the same sensitivities to HU, MMS, 
or UV, compared with WT cells (unpublished data). Fig. 3 C 
shows the abundance levels of various GFP-tagged Rad53 
  mutant proteins, indicating that the lack of bud neck loca-
lization of Rad53 mutant containing both NLS truncation and 
R70A mutations was not due to its reduced protein abundance. 
Table I. Summary of the binding proteins of FHA1 and -2 domains of Rad53 from cells untreated or treated by MMS
FHA1 speciﬁ  c FHA2 speciﬁ  c
Function Protein Accession 
no.
Description Detected in 
CTL
Detected in 
MMS
No. of 
peptides 
identiﬁ  ed
Detected in 
CTL
Detected in 
MMS
No. of 
peptides 
identiﬁ  ed
Validation Known Rad53 
binding protein
Nuclear
 DNA damage 
 checkpoint
Rad9 YDR217C Adaptor protein/
Rad53 activation
X3 X 2 0 Sun et al., 
1998
Mrc1 YCL061C X 4 
Ptc2 YER089C Phosphatase/
checkpoint 
inactivation
X X 3 Leroy et al., 
2003
 Transcription 
 factors and 
 cofactors
Swi6 YLR182W Regulation of 
cell cycle 
progression
XX4 
Mbp1 YDL056W X X 4 
Swi4 YER11C X X 3 
Whi5 YOR093W X X 2
Cst6 YIL036W Basic leucine 
zipper
XX4
Gln3 YER040W Nitrogen catabolite 
repression
XX3 
Ifh1 YLR223C Ribosome gene 
transcription
XX5 
 Other functions Esc1 YMR219W Telomeric 
silencing
XX6
Asf1 YJL115W Nucleosome 
assembly factor
XX3  Emil et al., 
2001; Hu et al., 
2001
Crp1 YHR146W Binds to 
cruciform 
DNA structures
XX 1 0 
Src1 YML034W Sister chromatid 
segregation 
(putative)
XX2 
Ecm16 YMR126W RNA helicase X X 2 
Net1 YJL076W Exit from mitosis X X 7 
Yta7 YGR270W ATPase/
bromodomain
XX3  Smolka et al., 
2005
Cytosolic
 Cytokinesis Cdc3 YLR314C Septins X X 23
Cdc12 YHR107C X X 20
Shs1 YDL225W X X 21 
Cdc11 YJR076C X X 11 
Cdc10 YCR002C X X 7 
Bud4 YJR092W Bud site selection X X 9 
Bud3 YCL014C X X 10 
Bud14 YAR014C X X 6 
 Other functions Sec2 YNL272C Protein trafﬁ  cking X X 16 
Ubp1 YDL122W Ubiquitin-speciﬁ  c 
protease
XX 2 0 
Rck2 YLR248W Protein kinase X X 13 
Fyv8 YGR196C Unknown X X 13 
Mnr2 YKL064W Unknown X X 2 
X indicates that the protein was detected in the condition used. Check marks indicate validation using FHA domain pull down and Western blot analysis, as described 
in the text. Some proteins were not validated because of technical problems in generating tagged strains.FHA DOMAIN–MEDIATED PROTEIN INTERACTION NETWORK OF RAD53 • SMOLKA ET AL. 747
  Although Rad53-GFP still underwent MMS-induced hyper-
phosphorylation and slower gel shift, truncation of Rad53 NLS 
largely abolished its MMS-induced hyperphosphorylation 
(Fig. 3 C). Therefore, the majority of Rad53 needs to be nuclear 
for its proper activation.
Rad53 is involved in the regulation 
of polarized cell growth in response 
to DNA replication stress
Because the FHA1 domain of Rad53 interacts with many pro-
teins, we asked what the role of the FHA1 domain of Rad53 
might be. We examined the effect caused by overexpression of 
the FHA domains of Rad53 in yeast cells. Overexpression of 
the FHA1 domain was found to result in aberrant cell morphol-
ogy, showing multiple elongated buds that fail to detach from 
the mother cell, even after zymolase treatment (Fig. 4 A). In 
contrast, overexpression of the R70A mutant FHA1 domain, or 
WT and the R605A mutant FHA2 domain, does not induce any 
such defect. Fig. 4 C shows the staining of a cell with overex-
pression of the FHA1 domain. It appears to be multinucleated 
and lacks any staining for septin Cdc11, suggesting that septin 
organization is disrupted by FHA1 overexpression.
We next asked whether any morphological defect could 
be observed in rad53∆ cells. No major morphological defect 
was detected in the untreated rad53∆ cells, although a closer 
analysis of rad53∆ cells did reveal various defects in budding 
pattern and cell wall integrity (see Enserink et al. on p. 729 
of this issue). Upon HU treatment, a striking morphological 
defect characterized by an elongated bud was readily observed 
for rad53∆ cells (Fig. 4, D and E). Such phenotype was ob-
served in  30% of rad53∆ and rad53-KD cells after 14 h of 
chronic HU treatment. Together, the results suggest that Rad53 
plays a role in the control of polarized cell growth in response 
Figure 2. Conﬁ  rmation of the binding speciﬁ  city of the FHA binding pro-
teins of Rad53. (A) Protein extracts from MMS-treated (0.1% MMS for 3 h) 
Rad9-HA or Mrc1-TAP cells were divided into equal fractions and subjected 
to pull-down assays using different GST fusion FHA domains as indicated. 
The GST-FHA domain used in the pull-down assay was stained by Ponceau 
as a control. Protein extracts from untreated Shs1-TAP, Cdc11-TAP, or Cdc10-
HA cells were subjected to the same FHA domain pull-down assays. 
(B) Binding of the FHA1 domain to septins is Cdc10 dependent. Single-deletion 
strains for different septins and septin-associated proteins were analyzed for 
the ability of the FHA1 domain to speciﬁ  cally bind TAP-tagged Cdc11.
Figure 3.  Rad53 can transiently localize to 
the bud neck. (A) Removal of the C-terminal 
NLS of Rad53 abrogates its predominant nu-
clear localization (compare two left views). 
Additional MMS treatment (0.05% for 3 h) led 
to a high percentage of cells with bud neck local-
ization of the NLS mutant Rad53-GFP. Closer 
inspection revealed a double ring–like local-
ization pattern of the Rad53 NLS mutant, as in-
dicated by the arrows. In contrast, the Rad53 
NLS mutant containing an additional R70A 
mutation fails to localize to the bud neck. DIC, 
differential interference contrast. (B) Quantita-
tive analysis of the cells showing localization 
of Rad53-NLS-GFP to the bud neck. Treatment 
of either 150 mM HU or 0.05% MMS for 3 h 
led to a substantial increase in the number of 
cells with a bud neck localization of the Rad53-
NLS-GFP. In each case, 200 cells were counted. 
(C) Abundances of various GFP-tagged Rad53 
were detected by anti-GFP Western blot (WB). 
Protein extracts were prepared from untreated 
and MMS-treated (0.01% for 4 h) cells. After 
detection, the membrane was stained with Pon-
ceau for loading control.JCB • VOLUME 175 • NUMBER 5 • 2006  748
to HU treatment, and its kinase activity appears to be essential 
for such regulation.
Shs1 participates in the response to DNA 
replication stress
The morphology defect caused by overexpression of the FHA1 
domain was found to be largely suppressed by deletion of Shs1 
(Fig. 5 A), suggesting that SHS1 may somehow function down-
stream of the FHA1-mediated binding of Rad53 to the septins. 
We then examined whether the SHS1∆ cells have any morpho-
logical defect in response to HU treatment. Interestingly, HU 
treatment of shs1∆ cells induces multiple elongated buds that 
fail to detach (Fig. 5 B), even after zymolase treatment. Interest-
ingly, Shs1 was effi  ciently phosphorylated by Rad53 in vitro 
(Fig. 5 C), raising the possibility that it may be a Rad53 sub-
strate. Next, we asked whether shs1∆ cells are hypersensitive to 
chronic treatment with HU. As shown in Fig. 5 D, although the 
shs1∆ cells are not sensitive to chronic treatment with HU at 
30°C, they are hypersensitive to HU treatment at 37°C. The 
shs1∆ cells are almost as sensitive as rad53 cells, and such loss 
of viability at 37°C is specifi  c to HU treatment, because shs1∆ 
cells are not sensitive at 37°C in the absence of HU, or even in 
the presence of MMS (Fig. 5 D). Collectively, these results sug-
gest that Shs1 may play an important role during the response to 
DNA replication stress, although the precise nature of such role 
is unknown.
Discussion
Numerous studies have suggested roles for Rad53 in the control 
of cell cycle arrest, histone turnover, control of late origin fi  ring, 
stabilization of stalled replication forks, and control of chromo-
some segregation (Allen et al., 1994; Paulovich and Hartwell, 
1995; Santocanale and Diffl  ey, 1998; Shirahige et al., 1998; 
Lopes et al., 2001; Gunjan and Verreault, 2003; Tercero et al., 
2003; Krishnan et al., 2004). Here, we identifi  ed a protein 
Figure 4.  Morphogenesis defects caused 
by impairing Rad53 function. (A) Galactose-
  induced overexpression of the WT FHA1 domain 
induces elongated buds. In contrast, overex-
pression of the FHA1 R70A mutant or WT and 
R605 mutant FHA2 proteins does not induce 
any visible defect. Protein extract of the cell 
cultures were prepared 10 h after galactose 
induction, and the expression level of the FHA 
domains was monitored by anti-Xpress West-
ern blot. The membrane was stained with Pon-
ceau for loading control. (B) Quantitation of 
the elongated bud phenotype. For each time 
point, at least 200 cells were counted in tripli-
cate experiments. (C) Example of a cell with 
an FHA1 domain–induced morphological de-
fect, zymolase treated and stained for DAPI, 
tubulin, and Cdc11. Cells are multinucleated 
and lack proper septin organization. (right) 
Staining of a cell after overexpression of the 
FHA1 domain with an R70A mutation, where 
normal Cdc11 staining is observed. The arrow 
indicates the staining of a normal septin ring. 
(D)  RAD53 deletion or kinase-dead exhibit 
elongated bud phenotype after treatment with 
150 mM HU. For each time point, at least 200 
cells were counted in triplicate experiments. 
Error bars indicate mean ± SD. (E) Example of 
the elongated bud phenotype observed for 
rad53∆, rad53-KD, and WT cells. All strains 
are in the RDKY5763 background.FHA DOMAIN–MEDIATED PROTEIN INTERACTION NETWORK OF RAD53 • SMOLKA ET AL. 749
interaction network mediated by the FHA domains of Rad53 
(Table I). It includes proteins involved in diverse cellular pro-
cesses, such as DNA damage checkpoints, cell cycle control, 
transcriptional regulation, and cytokinesis. The interaction be-
tween septins and the FHA1 domain of Rad53 led us to the 
fi  nding of a novel function for Rad53 in the regulation of polar-
ized cell growth.
The FHA domain–mediated protein 
interaction network of Rad53 
in the DNA damage response
The FHA domains of Rad53 appear to have distinct but overlap-
ping functions in the DNA damage response (Pike et al., 2003; 
Schwartz et al., 2003). Here, we show that the binding proteins 
for the FHA1 and -2 domains of Rad53 are quite different, with 
the exception of Rad9 (Table I). Previously, Rad9 was known to 
interact with both the FHA1 and -2 domains of Rad53, as it was 
suggested to mediate the activation of Rad53 (Schwartz et al., 
2002). Here, we further identifi  ed Mrc1, another adaptor pro-
tein in the DNA damage checkpoint, as a specifi  c binding 
  protein for the FHA1 domain, but not the FHA2 domain. As Mrc1 
is known to function in the maintenance of the DNA replication 
fork (Alcasabas et al., 2001; Osborn and Elledge, 2003), our 
observation immediately suggests that the FHA1 domain may 
have a specialized function in mediating cellular responses to 
DNA replication stress. Consistent with this suggestion, muta-
tions (R70A and N107A) in the FHA1 domain lead to elevated 
sensitivity to HU treatment and no detectable sensitivity to 
MMS treatment (unpublished data).
The FHA1 domain was found to also interact with a wide 
variety of proteins involved in several processes (Table I). Some 
of them have been identifi  ed previously, including Ptc2 and 
Asf1 (Leroy et al., 2003; Schwartz et al., 2003). However, most 
of the FHA1 interacting proteins are novel. Because many of 
these FHA1 binding proteins are not known to form protein 
complexes (Gavin et al., 2002; Ho et al., 2002), it is likely that 
they interact with the FHA1 domain of Rad53 independently. 
Some of them do form protein complexes, including the septins 
and the Swi6 complex. In these cases, the direct FHA1 binding 
partner is unknown. Swi6 was previously found to be a Rad53 
substrate (Sidorova and Breeden, 2003). Here, we found that 
the Swi6 complex binds to the FHA1 domain of Rad53, sug-
gesting that the FHA1 domain of Rad53 may facilitate the phos-
phorylation of Swi6 by Rad53. Similar mechanisms may also 
Figure 5.  Involvement of septin Shs1 in the re-
sponse to DNA replication stress. (A) Deletion of 
SHS1 rescues the elongated bud phenotype in-
duced by FHA1 domain overexpression. Protein 
extract of the cell cultures were prepared 10 h 
after galactose induction, and the expression 
level of the FHA domains was monitored by 
anti-Xpress Western blot. The membrane was 
stained with Ponceau for loading control. 
(B)  shs1∆ cells exhibit elongated buds after 
treatment with 150 mM HU for 6 h. (C) In vitro 
phosphorylation of individual septin compo-
nents by Rad53. Each septin was expressed 
and puriﬁ  ed from E. coli. Among these septins, 
Shs1 is the only septin efﬁ  ciently  phosphory-
lated by Rad53. (D) shs1∆ cells are hypersensi-
tive to replication stress at 37°C. Indicated cells 
(in RDKY5763 background) were plated on nor-
mal YPD plates or freshly prepared YPD plates 
containing 75 mM HU or 0.05% MMS. Cells 
were then grown at 30 or 37°C. Shs1 is re-
quired for cell viability at 37°C in the presence 
of HU. Note that shs1∆ cells are considerably 
more sensitive than dun1∆ cells under HU at 
37°C. A serial dilution of threefold was used.JCB • VOLUME 175 • NUMBER 5 • 2006  750
exist for other FHA1 binding proteins. Several nuclear proteins 
were found to be FHA1 binding proteins, including Net1, which 
functions in ribosomal DNA silencing and the regulation of mi-
totic exit (Shou et al., 1999; Straight et al., 1999), Esc1, which 
is implicated in gene silencing (Andrulis et al., 2002) and sup-
pression of gross chromosome rearrangements (Smith et al., 
2004), and others (Table I). Other known FHA1 binding pro-
teins, including Sgs1 (Bjergbaek et al., 2005), Dbf4 (Duncker 
et al., 2002), and Mdt1 (Pike et al., 2004), were not found here, 
probably because of their low abundance. Likewise, other low-
abundant proteins could exist and remain to be identifi  ed by 
more sensitive techniques.
It is interesting to note that after DNA damage treatment, 
Rad9 and Mrc1 are the only additional proteins found to inter-
act with the FHA domains of Rad53, whereas binding of the 
other FHA1 binding proteins is independent of DNA damage 
treatment. This leads to the hypothesis that in the absence of 
DNA damage stresses, Rad53 is in a dynamic binding equi-
librium  with many FHA1 binding proteins, yet the kinase 
remains mostly inactive. In response to DNA damage or repli-
cation stress, Rad53 is temporarily recruited to Rad9 or Mrc1 
via its FHA domains, for its activation (Alcasabas et al., 2001; 
Gilbert et al., 2001). Once activated, Rad53 may phosphorylate 
its downstream targets as facilitated by the FHA1 and -2 
domains (Fig. 6).
Rad53 is involved in the regulation 
of polarized cell growth under DNA 
replication stress
Several lines of evidence support the idea that Rad53 may regu-
late polarized cell growth in response to DNA replication stress. 
First, the FHA1 domain of Rad53 binds specifi  cally to septins. 
Second, consistent with the binding between Rad53 and septins, 
an NLS truncation mutant of Rad53 transiently localizes to the 
bud neck in an FHA1-dependent manner. We have attempted to 
visualize a localization of WT Rad53 to the bud neck in various 
mutants that fail to position the nucleus close to the bud neck 
(kar9∆ and dyn1∆). However, because of the low abundance of 
WT Rad53 outside of the nucleus, we could not conclusively 
detect Rad53 at the bud neck. Third, overexpression of the 
FHA1 domain of Rad53 induces a morphological defect and 
defective septin organization. Fourth, rad53∆ and rad53-KD 
cells treated by HU exhibit elongated bud growth. Additionally, 
the role of Rad53 in the regulation of polarized cell growth is 
further supported by the observation of various morphological 
defects of rad53∆ cells (Enserink et al., 2006).
We further propose that Shs1 may function in the response 
to replication stress. Deletion of Shs1 results in a strong HU-
  induced morphological defect and abolishes the morphological 
defect caused by overexpression of the FHA1 domain. Besides 
being a good substrate for Rad53 phosphorylation in vitro, Shs1 
was also found to be required for cell viability under DNA rep-
lication stress at 37°C. However, the precise role of Shs1 is still 
unclear. We are now characterizing the in vivo phosphorylation 
of Shs1 and, consistent with the in vitro results reported here, 
we have detected at least one in vivo Rad53-dependent phos-
phorylation site on Shs1 and are assessing its biological relevance. 
Furthermore, because septins provide a site where many regula-
tory proteins are known to localize (Longtine and Bi, 2003), 
Rad53 may also regulate other septin-associated proteins 
under DNA replication stress. It is possible that a concerted ac-
tion from multiple pathways contributes to how Rad53 regu-
lates polarized cell growth in budding yeast. Collectively, we 
propose that Rad53 controls proper polarized cell growth 
during DNA replication.
In summary, a network of FHA binding proteins has been 
identifi  ed for Rad53. The FHA-mediated interaction of Rad53 
with Rad9 and Mrc1 likely functions in the activation of Rad53 
and targets Rad53 to the site of DNA damage or to the DNA 
replication fork. Further, a network of Rad53 FHA1 binding 
proteins suggests a role of Rad53 in coordinating a global cellu-
lar response, including the regulation of polarized cell growth in 
yeast. Understanding the role of each FHA binding protein of 
Rad53 in the DNA damage response should further shed light 
on its diverse functions.
Materials and methods
Yeast strains, plasmids, and genetic methods
Strains used in this work are listed in Table S1 (available at http://www.
jcb.org/cgi/content/full/jcb.200605081/DC1). All strains of TAP-tagged 
proteins were obtained from the Open Biosystems collection. For epitope 
tagging of Rad53, the RDKY5763 cells (ura3-52, leu2∆1, trp1∆63, 
his3∆200, lys2∆Bgl, hom3-10, ade2∆1, ade8, YEL069C::URA3, and 
sml1::TRP1) were used. For deletion or epitope tagging of Bud3, Bud4, 
Bud14, Cdc10, and Shs1, BY4741 and RDKY5763 cells were used. To 
generate endogenous C-terminal–tagged Cdc10-3xHA, Rad9-3xHA, and 
Rad53-GFP, we used standard homologous recombination technique and 
the pFA6a plasmids (a gift from M. Longtine, Oklahoma State University, 
Stillwater, OK; Longtine et al., 1998). To make GFP-tagged Rad53 NLS 
truncation mutant, GFP was fused to the C-terminal end of endogenous 
Rad53 with concurrent removal of the amino acid 781 to the C terminus. 
To generate a kinase-dead mutant of Rad53, Rad53 was ﬁ  rst cloned into 
pFA6a and mutated and then the mutant Rad53 was reintroduced back 
into the endogenous RAD53 locus in rad53 cells. Correct integration and 
mutations were all veriﬁ  ed by DNA sequencing.
Figure 6.  A network of Rad53 FHA domain binding proteins. In the 
absence of exogenous DNA damage treatment, the FHA1 domain of 
Rad53 is in a dynamic binding equilibrium with many FHA1 binding 
proteins, yet the kinase remains mostly inactive. In response to DNA 
damage or replication stress, Rad53 is recruited to Rad9 or Mrc1 for ac-
tivation, via both its FHA domains. We propose that the dynamic binding 
equilibrium of active Rad53 with its FHA domain binding proteins assists 
in substrate targeting.FHA DOMAIN–MEDIATED PROTEIN INTERACTION NETWORK OF RAD53 • SMOLKA ET AL. 751
Plasmids used in this work are listed in Table S2 (available at 
http://www.jcb.org/cgi/content/full/jcb.200605081/DC1). For over-
expression studies, WT and mutant FHA1 (amino acid residues 2– 279) and 
FHA2 (amino acid residues 523–821) domains of Rad53 were cloned into 
pYES2/NT-C vector (Invitrogen) using BamHI and NotI restriction sites. For 
pull-down assays, the same FHA domains were subcloned into pGEX-4T1. 
To make the PATH tag, a sequence containing the protein A and TEV cleav-
age site was ﬁ  rst  ampliﬁ   ed from the plasmid pREP1 NT (a gift from 
K. Gould, Vanderbilt University School of Medicine, Nashville, TN; Tasto 
et al., 2001) using a primer containing a 6xHis tag sequence and then in-
serted into the pET21a plasmid (Novagen) using NdeI and BamHI, result-
ing in the PATH plasmid. Different FHA domains were then subcloned into 
the PATH plasmid using the same restriction sites. Mutant FHA was gener-
ated using site-directed mutagenesis. In each case, the sequence is con-
ﬁ  rmed by DNA sequencing.
Expression and puriﬁ  cation of PATH-FHA proteins and GST fusion proteins
The PATH-FHA1 (amino acid residues 2–279) and -FHA2 (amino acid resi-
dues 523–821) domains of Rad53 and their respective mutants (R70A and 
R605A) were expressed in BL21 cells and induced by 0.1 mM IPTG at 
30°C for 3 h. Cells were harvested and lysed by sonication in TBS-N 
(20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.2% NP-40) with protease 
inhibitors (5 mM EDTA, 1 mM PMSF, 0.2 mM benzamidine, 1 μM leu-
peptin, and 1.5 μM pepstatin). Cell debris was removed by centrifugation 
at 30,000 g for 30 min. The cleared cell extract was incubated with IgG-
Sepharose (GE Healthcare) for 2 h and washed extensively by TBS-N. 
Purity and abundance of bound PATH-FHA proteins on the IgG resin were 
examined by either TEV protease cleavage or boiling in SDS sample buffer 
and subsequent SDS-PAGE analysis. Typically, the procedure resulted in a 
concentration of 5 μg FHA protein per μl of IgG resin. To make GST fusion 
proteins, GST-FHA proteins or GST-tagged septins were similarly expressed 
in BL21 cells. Glutathione resin was used for their puriﬁ  cation according to 
manufacturer’s instruction (GE Healthcare).
PATH puriﬁ  cation of FHA-interacting proteins
2 liters of yeast cells (BY4741) were grown in YPD medium to an OD600 of 
1.5. Approximately 10 g of cells were broken in an ice-cooled bead beater 
with 40 ml lysis buffer containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
0.2% NP-40, 0.5 mM DTT, 5 mM NaF, 10 mM β-glycerolphosphate, 1 mM 
sodium vanadate, 5 mM EDTA, 1 mM PMSF, 0.2 mM benzamidine, 1 μM 
leupeptin, and 1.5 μM pepstatin. Cell debris was removed by centrifuga-
tion at 30,000 g for 30 min. Protein extract was divided into two equal 
fractions, each incubated with 0.1 ml of WT or the mutant PATH-FHA con-
taining IgG resin overnight at 4°C. The resins were then washed with 
20 ml of lysis buffer and resuspended in 1.5 ml of lysis buffer without EDTA. 
The FHA domain was cleaved off by adding 100 units of TEV protease 
(Invitrogen) for 2 h at room temperature. Supernatant containing 6xHis-
tagged FHA protein and its interacting proteins was collected and was 
further incubated with 0.1 ml of Ni-NTA resin (QIAGEN) for 1 h at room 
temperature. The Ni-NTA resin was washed with 10 ml of lysis buffer and 
then with 5 ml of TBS buffer. To elute the FHA binding proteins (but not the 
FHA domain), the Ni-NTA resin was incubated for 5 min at 80°C in 400 
μl of an elution buffer containing 8 M urea, 100 mM Tris-HCl, pH 8.0, and 
500 mM NaCl. Eluted proteins were reduced and alkylated before trypsin 
digestion, as described previously (Smolka et al., 2005). For MMS treat-
ment, 0.05% of MMS was added to cells for 2 h before harvesting.
Western blot analysis
To conﬁ  rm the binding speciﬁ  city of FHA binding proteins, 50 ml of yeast 
cells containing a TAP- or HA-tagged gene of interest was grown in YPD to 
an OD of 1.0. Cells were harvested and broken by vortexing with glass 
beads. The cleared cell extract was then incubated with the same amount 
of WT or mutant GST-FHA proteins bound to glutathione resin. After bind-
ing, the resins were washed by 4 × 1 ml of TBS-N, boiled in SDS sample 
buffer, and subjected to Western blot analysis using anti-TAP antibody 
(Open Biosystems) or anti-HA antibody (Roche Applied Science).
In vitro phosphorylation assay of septins by Rad53
Recombinant 6xHis-Rad53 was used to phosphorylate septins in vitro 
(Smolka et al., 2005). Approximately 5–10 μg of GST-fused Cdc3, Cdc10, 
Cdc11, Cdc12, or Shs1 were incubated with 100 ng of Rad53 in 20 μl 
of kinase buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.2% NP-40, 
0.2 mM ATP, and 10 μC ATP
32) for 40 min at 30°C. After phosphorylation, 
the samples were boiled in SDS sample buffer with DTT for 5 min, and 10% 
of the sample was analyzed by SDS-PAGE and subjected to autoradiography. 
Plasmids encoding GST fusion of septins were a gift from J. Thorner 
(University of California, Berkeley, Berkeley, CA).
N-isotag labeling of peptides
For labeling of the amino groups of peptides, we used an isotope-coded 
leucine-containing N-isotag reagents. The d0-tBoc-Leu-NHS reagent was 
purchased from Nova Biochem. The d10-tBoc-Leu-NHS was synthesized 
using the method described previously (Smolka et al., 2005). The light N-
isotag, i.e., d0-tBoc-Leu-NHS, was used to label WT FHA binding proteins, 
whereas the d10-tBoc-leu-NHS was used to label mutant FHA binding pro-
teins. The labeling procedure was performed as described previously 
(Smolka et al., 2005).
Mass spectrometry and data analysis
Samples were analyzed by μLC-ESI-MS/MS on a quadrupole ion trap 
mass spectrometer (Finnigan LCQ; Thermo Electron Corporation) as previ-
ously described (Smolka et al., 2005). For data analysis, SEQUEST was 
used for peptide identiﬁ  cation, and the XPRESS and INTERACT software 
were used for quantitation as described previously (Smolka et al., 2005). 
The complete yeast database was used to analyze MS/MS spectra with no 
restriction on the enzyme used, and a variable modiﬁ  cation of serine and 
threonine residues by phosphorylation was included in the database 
search. Only the top-matched, doubly tryptic peptides with high-quality 
MS/MS spectra were subsequently subjected to manual inspection. All 
proteins listed in Table I were identiﬁ  ed with at least two different peptides, 
both containing the light N-isotag labeling reagent, which was used to 
label WT FHA binding proteins.
Microscopy
Microscopy was performed on live cells resuspended in water. Images were 
taken with a microscope (Axiovert 200; Carl Zeiss MicroImaging, Inc.), 
coupled to a camera (Axiocam HRc; Carl Zeiss MicroImaging, Inc.), and the 
AxioVision software version 4.4.1.0 (Carl Zeiss MicroImaging, Inc.).
For confocal imaging, yeast were grown to log phase (OD600  0.1) 
and treated with various agents before imaging. Imaging was done on a 
spinning disk confocal (McBain Instruments) mounted live in minimal media 
on an inverted microscope (TE2000e; Nikon). Images were acquired using 
a 60× 1.4 NA Plan Apo objective lens with 1.5× auxiliary magniﬁ  cation 
(90× magniﬁ  cation total) using a charge-coupled device camera (Orca ER; 
Hamamatsu) with 2 × 2 binning. Acquisition parameters, shutters, and fo-
cus were controlled by MetaMorph software (Universal Imaging). All ﬂ  uo-
rescence images were acquired using the same settings, including laser 
intensity. Each ﬂ  uorescence image presented is a maximum intensity projec-
tion of a z-series stack through the entire yeast cell (5–8 μm), whereas a sin-
gle differential interference contrast image was acquired at the midpoint of 
the z stack. All imaging was conducted at room temperature ( 23°C).
Immunoﬂ  uorescence samples were processed and mounted as pre-
viously described (Cheeseman et al., 2002), and images were acquired 
using an upright microscope (E800; Nikon) with conventional multimode 
optics. Differential interference contrast, DAPI, FITC, and Rhodamine im-
ages were acquired using a 60× 1.4 NA Plan Apo objective lens and 
MetaMorph software controlling the Orca ER charge-coupled device cam-
era with 1 × 1 binning. Each ﬂ  uorescence image presented is a maximum 
intensity projection of a z-series stack through the entire yeast cell (5–8 μm), 
whereas a single differential interference contrast image was acquired at 
the midpoint of the z stack. All imaging was conducted at room tempera-
ture ( 23°C). Images were processed in MetaMorph for brightness and 
contrast and minimal gamma adjustments.
Online supplemental material
Fig. S1 shows conﬁ   rmation of the FHA1 binding proteins. Table S1 
lists yeast strains used in this study. Table S2 lists plasmids used in this 
study. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200605081/DC1.
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